India to Philippines: Amiodarone Export Trade Route
India has recorded 19 verified shipments of Amiodarone exported to Philippines, representing a combined trade value of $420.9K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $22.2K USD. The leading Indian exporter is STALLION LABORATORIES PVT LTD, which accounts for 23% of total export value with 5 shipments worth $95.3K USD. On the buying side, TROIKAA PHARMACEUTICALS PHILIPPINES is the largest importer in Philippines with $90.0K USD in purchases. The top 3 suppliers — STALLION LABORATORIES PVT LTD, TROIKAA PHARMACEUTICALS LIMITED , TROIKAA PHARMACEUTICALS LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Amiodarone corridor is one of India's established pharmaceutical export routes, with 19 shipments documented worth a combined $420.9K USD. The route is dominated by STALLION LABORATORIES PVT LTD, which alone accounts for roughly 23% of all export value, reflecting the consolidated nature of India's amiodarone manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $22.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with amiodarone's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 31.5%, placing it at rank #4 among India's top amiodarone export destinations globally.
On the import side, key buyers of Indian amiodarone in Philippines include TROIKAA PHARMACEUTICALS PHILIPPINES , TROIKAA PHARMACEUTICALS PHILIPPINES, TO THE ORDER OF and 6 others. TROIKAA PHARMACEUTICALS PHILIPPINES is the single largest importer with 2 shipments valued at $90.0K USD.
